[HTML][HTML] An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang, G Zhang… - One Health …, 2023 - Springer
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
[PDF][PDF] An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang, G Zhang, L Ye… - 2023 - scienceopen.com
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
[HTML][HTML] An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang… - One Health …, 2023 - onehealthadv.biomedcentral.com
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang… - One Health …, 2023 - europepmc.org
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang… - One health …, 2023 - pubmed.ncbi.nlm.nih.gov
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
[HTML][HTML] An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang… - One Health …, 2023 - ncbi.nlm.nih.gov
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
[PDF][PDF] An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant
M Yuan, Y Zhu, G Liu, Y Wang, G Wang, G Zhang… - 2023 - onehealthadv.biomedcentral.com
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
An RBD bispecific antibody effectively neutralizes a SARS-CoV-2 Omicron variant.
M Yuan, Y Zhu, G Liu, Y Wang, G Wang… - One Health …, 2023 - europepmc.org
Potent neutralizing antibodies (nAbs) against SARS-CoV-2 are a promising therapeutic
against the ongoing COVID-19 pandemic. However, the continuous emergence of …
against the ongoing COVID-19 pandemic. However, the continuous emergence of …